Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 48
Filter
1.
J Drugs Dermatol ; 22(12): e44-e46, 2023 12 01.
Article in English | MEDLINE | ID: mdl-38051829

ABSTRACT

Dermatology is one of the most competitive residencies for matching among medical school applicants. A strong connection with a residency program through research or clinical rotations may distinguish between similarly qualified applicants. Our previous study of research-mentor relationships among matched dermatology applicants corroborated the importance of program connections.1 However, the 2020-2021 residency match cycle was uniquely affected by the COVID-19 pandemic, which prevented applicants from fostering connections with faculty at outside institutions. Our study objectives were to evaluate research-mentor relationships among matched dermatology applicants in the 2020-2021 pandemic match cycle with comparisons to pre-pandemic match cycles.


Subject(s)
COVID-19 , Dermatology , Internship and Residency , Humans , Mentors , Dermatology/education , Pandemics , COVID-19/epidemiology
2.
J Drugs Dermatol ; 22(4): 413-416, 2023 Apr 01.
Article in English | MEDLINE | ID: mdl-37026881

ABSTRACT

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of antidiabetic agents that work by inducing insulin secretion and inhibiting release of glucagon in a glucose-dependent manner. They are especially promising given their long duration of action, decreased risk of hypoglycemia, and added benefit of weight loss. Semaglutide is a GLP-1 receptor agonist that has been approved for type II diabetes and chronic weight management in obese adults. Cases of hypersensitivity reactions have been previously reported in patients taking GLP-1 receptor agonists dulaglutide and liraglutide. However, to our knowledge, there have been no reports of hypersensitivity reactions to semaglutide. Here, we present two cases of dermal hypersensitivity reactions in patients taking semaglutide for type II diabetes. In the first case, a 75-year-old woman who had been taking semaglutide for 10 months presented with an eruption on her legs, back, and chest for 3 months duration. Histology showed a subepidermal blister with eosinophils, suggestive of a drug hypersensitivity reaction. In the second case, a 74-year-old white man who had been taking semaglutide for 1 month presented with an eruption on the bilateral flanks and lower abdomen for 3 weeks duration. Histology revealed perivascular inflammatory cell infiltrate with eosinophils, also suggestive of a drug hypersensitivity reaction. Both patients began experiencing resolution of their symptoms within 1 month of discontinuing semaglutide. J Drugs Dermatol. 2023;22(4): doi:10.36849/JDD.6550 Citation: Ouellette S, Frias G, Shah R, et al. Dermal hypersensitivity reaction to semaglutide: Two case reports. J Drugs Dermatol. 2023;22(4):413-415. doi:10.36849/JDD.6550.


Subject(s)
Diabetes Mellitus, Type 2 , Drug Hypersensitivity , Hypersensitivity , Humans , Male , Adult , Female , Aged , Diabetes Mellitus, Type 2/drug therapy , Glucagon-Like Peptide-1 Receptor/agonists , Hypoglycemic Agents/adverse effects , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/etiology
3.
Dermatol Ther ; 35(12): e15945, 2022 12.
Article in English | MEDLINE | ID: mdl-36259229

ABSTRACT

Methotrexate (MTX) is a chemotherapeutic agent that acts primarily by inhibiting the folic acid cycle. In addition to its application for treating malignancies, MTX is also used to treat chronic inflammatory diseases including psoriasis. Adverse effects have been reported even at low doses (up to 25 mg/week), and there is risk of toxicity in the form of myelosuppression, hepatotoxicity, or pulmonary fibrosis.Ā Here, we report a case of a 67-year-old male with a past medical history of end stage renal disease on peritoneal dialysis and moderate-to-severe psoriasis with psoriatic arthritis presented with abdominal pain, diarrhea, rash, mucositis, and mucocutaneous ulcers and erosions. The patient was taking methotrexate 10 mg weekly without folic acid supplementation and was found to be pancytopenic. Despite treatment, the patient developed multiorgan failure and passed away after 16 days of hospitalization. Myelosuppression is considered the most serious side effect with the highest risk of mortality. Risk factors for toxicity include renal insufficiency, advanced age, lack of folate supplementation, drug interactions, and medication errors. Importantly, serum levels of MTX do not correlate with toxicity; therefore, folinic acid rescue therapy should be started as soon as MTX toxicity is suspected. MTX toxicity is rare with low dose, proper dose scheduling, and adherence to the recommended guidelines. It is imperative that physicians considering therapy with low dose MTX for dermatologic indications take into consideration a patient's risk factors for toxicity and monitor appropriately.


Subject(s)
Arthritis, Psoriatic , Drug-Related Side Effects and Adverse Reactions , Psoriasis , Male , Humans , Aged , Methotrexate , Folic Acid , Psoriasis/drug therapy , Psoriasis/chemically induced , Risk Factors , Arthritis, Psoriatic/drug therapy
4.
Skin Res Technol ; 28(2): 365-367, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34751469

ABSTRACT

Dermatofibrosarcoma protuberans (DFSP) is an overall rare malignancy yet is one of the most common cutaneous sarcomas. The diagnosis of DFSP is typically made following histopathologic examination of the lesion, classically revealing a storiform pattern of spindle cells with elongated nuclei infiltrating the dermis and subcutis. Surgical excision is the standard treatment. Local recurrence is estimated to occur in 20-50% of cases, thus frequent postsurgical monitoring is required. Noninvasive imaging modalities offer a potential alternative to multiple repeat biopsies. We report the first case where reflectance confocal microscopy accompanied clinical examination in monitoring for DFSP recurrence postsurgical excision.


Subject(s)
Dermatofibrosarcoma , Skin Neoplasms , Dermatofibrosarcoma/diagnostic imaging , Dermatofibrosarcoma/surgery , Humans , Microscopy, Confocal , Skin Neoplasms/diagnostic imaging , Skin Neoplasms/surgery , Skin Transplantation
5.
Am J Dermatopathol ; 44(3): 212-214, 2022 Mar 01.
Article in English | MEDLINE | ID: mdl-34726186

ABSTRACT

ABSTRACT: Primary dermal melanoma (PDM) is defined as a primary melanoma tumor confined to the dermis, subcutis, or both, without epidermal involvement. The significant overlap of histopathological features in PDM and cutaneous metastatic melanoma makes diagnostic accuracy of PDM challenging. We present a case of a 48-year-old man with a nontender 1.5 Ɨ 1.5 cm subcutaneous nodule on the left leg, which had been present for years. Biopsy revealed a dermal tumor with melanocytic differentiation noted to be positive for SOX-10. Additional pathology findings included a high Ki-67 proliferation index and a loss of p16 expression. Pathology reports were consistent with primary tumor stage 4a, and the patient was referred to surgical oncology where examination and workup demonstrated no evidence of the residual lesion representing a metastasis from a primary site. As PDM is histologically indistinguishable from melanoma metastasis to the skin, clues including a history of an evolving subepidermal nodule and exclusion of previous or concurrent melanomas can assist in its accurate diagnosis. Currently, a consensus on the criteria, staging, and management of PDM does not exist. Poorly defined diagnostic criteria and general lack of awareness of PDM result in high rates of incorrect and late-stage diagnoses. This case report highlights the importance of physician familiarity with PDM to ensure accurate recognition, evidence-based management, and improved patient outcomes.


Subject(s)
Dermis/pathology , Melanoma/pathology , Subcutaneous Tissue/pathology , Dermis/surgery , Humans , Male , Melanoma/surgery , Middle Aged , Subcutaneous Tissue/surgery
6.
J Drugs Dermatol ; 21(3): 304-308, 2022 Mar 01.
Article in English | MEDLINE | ID: mdl-35254761

ABSTRACT

Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin tumor that presents as an erythematous or violaceous nodule in elderly white males with an extensive history of sun exposure. Herein, we report two cases of extrafacial MCC. On exam, lesions presented as a cystic nodule and a firm plaque. We summarize tools from literature review that may aid in earlier diagnosis of MCC as well as implications of primary tumor location in prognosis. In addition, we provide an algorithm for diagnostic workup. MCC is an aggressive malignancy with a poor prognosis and a high risk of local recurrence and nodal metastasis. It is imperative to include MCC in differential diagnosis of cyst/nodule in order to facilitate early detection. J Drugs Dermatol. 2022;21(3):304-308. doi:10.36849/JDD.6248.


Subject(s)
Carcinoma, Merkel Cell , Cysts , Skin Neoplasms , Aged , Algorithms , Carcinoma, Merkel Cell/diagnosis , Carcinoma, Merkel Cell/pathology , Cysts/pathology , Diagnosis, Differential , Humans , Male , Prognosis , Skin/pathology , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology
7.
J Cutan Pathol ; 47(12): 1170-1174, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32643790

ABSTRACT

Pigmented extramammary Paget disease (PEMPD) is a rare intraepithelial carcinoma which can clinically resemble other pigmented neoplasms. Similarities to melanoma on dermoscopy, histopathology, and reflectance confocal microscopy (RCM) increase the risk of misdiagnosis and, consequently, mismanagement. Here, we describe a case of a 67-year-old African American woman with a large, pigmented axillary patch that exhibited features of melanoma on RCM, guiding the clinician to perform an excisional biopsy. While traditional histopathology resembled melanoma, immunohistochemistry staining was performed and revealed PEMPD. We highlight an uncommon clinical presentation of PEMPD disease and identify morphologic mimickers of melanoma on RCM-as well as differentiating features.


Subject(s)
Axilla/pathology , Melanoma/diagnostic imaging , Microscopy, Confocal/methods , Paget Disease, Extramammary/pathology , Black or African American/ethnology , Aged , Biopsy/methods , Dermoscopy/methods , Diagnosis, Differential , Diagnostic Errors/statistics & numerical data , Female , Humans , Hyperpigmentation/pathology , Hyperplasia , Immunohistochemistry/methods , Keratins/metabolism , Melanocytes/pathology , Melanoma/pathology , Microscopy, Confocal/statistics & numerical data , Paget Disease, Extramammary/diagnosis , Paget Disease, Extramammary/metabolism
8.
Pediatr Dermatol ; 37(5): 979-980, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32749028

ABSTRACT

Cutis marmorata telangiectatica congenita (CMTC) is a rare congenital cutaneous vascular anomaly with a reticular marbled erythematous pattern, which can result in isolated benign skin lesions or less commonly be associated with systemic anomalies. Occasionally, the characteristic pattern of CMTC lesions is masked on initial presentation, creating a diagnostic conundrum that can result in unnecessary workups to rule out vasculopathy. We present the case of a female newborn with a red-blue ulcerated skin lesion on the right leg and foot, which initially appeared as retiform purpura but evolved to exhibit the mottled pattern of CMTC by 5Ā days of age. Clinicians must be made aware of this potential diagnostic trap in early CMTC to avoid invasive skin biopsies and unnecessary laboratory testing in neonates.


Subject(s)
Purpura , Skin Diseases, Vascular , Telangiectasis/congenital , Female , Humans , Infant, Newborn , Livedo Reticularis , Purpura/diagnosis
9.
J Drugs Dermatol ; 17(11): 1234-1235, 2018 11 01.
Article in English | MEDLINE | ID: mdl-30500147

ABSTRACT

Cosmetic consultations are routinely part of a dermatologist's day. Often, patients present after consultation from another dermatologist or other physician with an established diagnosis and would like a particular treatment to resolve their condition. However, it is imperative to take a full history and physical exam prior to rendering treatment in the event of a missed or new diagnosis.


Subject(s)
Cosmetic Techniques , Hemangiosarcoma/diagnosis , Skin Neoplasms/diagnosis , Biopsy , Hemangiosarcoma/pathology , Hemangiosarcoma/therapy , Humans , Lasers , Male , Middle Aged , Nasal Surgical Procedures/methods , Nose/surgery , Radiotherapy, Adjuvant , Skin Neoplasms/pathology , Skin Neoplasms/therapy
13.
J Am Acad Dermatol ; 69(6): e295-300, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24035553

ABSTRACT

BACKGROUND: Reflectance confocal microscopy (RCM) is an imaging tool that allows the visualization of cellular details without biopsy. To our knowledge, RCM sensitivity and specificity has not been studied in a telemedicine setting. OBJECTIVE: We sought to assess RCM diagnostic accuracy in a support teleconsultation setting. METHODS: Between June 2010 and September 2011, 340 lesions were imaged using a confocal scanning microscope. The images were evaluated by 2 readers, one on site, and the other at a distance. RESULTS: A total of 334 cases were included. For each reader the sensitivity was greater than 90% and specificity for each reader was greater than 60%. Both readers had a combined sensitivity of 98.6% and 44% specificity. LIMITATIONS: RCM may be limited in the correct classification of epithelial tumors. CONCLUSIONS: RCM is a tool in the clinical diagnosis of skin lesions, providing a high diagnostic accuracy in teleconsultation use.


Subject(s)
Clinical Competence , Dermatology , Skin Diseases/pathology , Telepathology , Humans , Microscopy, Confocal/methods , Microscopy, Confocal/standards , Point-of-Care Systems , Reproducibility of Results
14.
J Drugs Dermatol ; 12(6): 685-91, 2013 Jun 01.
Article in English | MEDLINE | ID: mdl-23839187

ABSTRACT

INTRODUCTION: Vitiligo is a condition caused by the destruction of melanocytes, resulting in areas of skin without pigmentation. While many topical therapies exist for its treatment, not all patients respond to such treatments. Various surgical, laser and other alternative therapies are available for use as well. OBJECTIVE: The objective of this review was to describe the various surgical, laser, and alternative therapies available for vitiligo. A literature review was conducted through Pubmed and Ovid using the search terms "Vitiligo treatment", "Vitiligo surgery", "Vitiligo laser". Since no articles were available about needling on both Pubmed and Ovid using the search criteria, individual articles were sought out through Google. RESULTS: The literature review yielded many possible surgical interventions including autologous mini-punch grafting, suction epidermal blister grafting, split-thickness grafting, and cultured and noncultured melanocyte keratinocyte transfer. Laser options included the helium-neon and xenon-chloride lasers, with tattooing and needling serving as other options. While all the above techniques can provide improvement to pigmentation in vitiliginous patches, physician comfort and experience are important factors with regards to outcome. Our case series of four patients treated with the needling method yielded favorable results, with repigmentation rates ranging from 25-50%, with one patient having 90% repigmentation. CONCLUSION: There are many surgical, laser, and alternative treatment options available for vitiligo when conventional medical therapy fails or for use in conjunction with medical therapies. Autologous mini punch grafting and needling both have minimal equipment requirements and are easy to learn. Physician experience and comfort play a large role in outcome and availability of services.


Subject(s)
Complementary Therapies/methods , Laser Therapy/methods , Vitiligo/therapy , Adolescent , Adult , Aged , Humans , Keratinocytes/transplantation , Melanocytes/metabolism , Melanocytes/transplantation , Needles , Skin Pigmentation , Tattooing , Vitiligo/pathology , Vitiligo/surgery
15.
J Cosmet Laser Ther ; 14(2): 50-8, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22372471

ABSTRACT

Cellulite is a disorder in which adipose tissue extends through the dermis, producing a cosmetically displeasing dimpling in the affected areas. While many treatments claim to be able to improve the appearance of cellulite, the long-term effectiveness of these treatments and whether the logic behind these treatments can lead to a long-term improvement has not been extensively reviewed. In the following review, our goal is to assess the various cellulite treatments and evaluate the length of time results persist and whether the science behind the treatments warrants them as reliable and effective treatments for cellulite.


Subject(s)
Connective Tissue Diseases/therapy , Cosmetic Techniques , Subcutaneous Fat , Humans , Lipectomy , Massage , Mesotherapy , Phototherapy , Radiofrequency Therapy , Suction , Time Factors , Ultrasonic Therapy
16.
J Drugs Dermatol ; 11(9): 1111-3, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23135657

ABSTRACT

BACKGROUND: Discoid lupus erythematosus (DLE) is an inflammatory condition characterized by round demarcated lesions with varying amounts of erythema, telangiectasia, scaling, follicular plugging, dyspigmentation, atrophy, and scarring. Clinical diagnosis can be confirmed through biopsy samples; reflectance confocal microscopy (RCM) is also emerging as an accurate diagnostic tool. OBJECTIVE AND METHODS: Our objective was to examine the features of discoid lupus erythematosus on reflectance confocal microscopy. Two patients presenting with discoid lupus erythematosus were imaged using RCM. Features seen in RCM were correlated with those seen in histopathology. RESULTS: Reflectance confocal microscopy images of discoid lupus erythematosus yielded features characteristically seen in histopathological samples including inflammatory cells, inflammation at the dermo-epidermal junction, pigment incontinence, and vacuolar degeneration. CONCLUSION: Reflectance confocal microscopy is a useful tool in the diagnosis of discoid lupus erythematosus. Features described in these two cases as well as prior research have yielded sufficient data to allow for the formulation of useful RCM diagnostic algorithms. Further studies with a larger patient population will help in confirming and describing new features of DLE on RCM.


Subject(s)
Inflammation/pathology , Lupus Erythematosus, Discoid/pathology , Microscopy, Confocal/methods , Algorithms , Biopsy , Female , Humans , Inflammation/diagnosis , Inflammation/etiology , Lupus Erythematosus, Discoid/diagnosis , Middle Aged
17.
Cutis ; 90(5): 244-7, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23270195

ABSTRACT

Pityriasis rubra pilaris (PRP) is a chronic papulosquamous eruption of the skin characterized by follicular hyperkeratosis, salmon pink scaly plaques with islands of unaffected skin, and palmoplantar keratoderma. Widely used oral systemic and topical treatments are not greatly effective. We present a 62-year-old man with PRP of 2 years' duration who used routine topical treatments, oral retinoids, and UV therapy without improvement, but his symptoms greatly improved with the initiation of adalimumab.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Antibodies, Monoclonal, Humanized/administration & dosage , Antibodies, Monoclonal, Humanized/therapeutic use , Pityriasis Rubra Pilaris/drug therapy , Pityriasis Rubra Pilaris/pathology , Adalimumab , Humans , Injections, Subcutaneous , Male , Middle Aged
18.
Cureus ; 14(4): e24126, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35573488

ABSTRACT

As the onset of novel variants of the severe acute respiratory syndrome coronavirus 2 virus pushes policy-makers to push widespread vaccination efforts, it is likely that an increased number of severe cutaneous adverse reactions (SCARs) will present. Therefore, it is important to understand the presentation of possible SCARs. However, data are limited regarding which SCARs are most likely to be found following vaccination, and specific presentations in certain demographic groups, such as postmenopausal women, remain widely unknown. Here, we present the case of a 73-year-old female with no medical history or allergies presenting with a unique reaction of systemic bullous pemphigoid following the Moderna mRNA-1273 vaccine. To our knowledge at the time of this writing, based on a thorough review of the literature using PubMed, no such cases exist following the Moderna vaccine in the United States in elderly, postmenopausal women. We present a brief discussion on the presentation and management to hopefully alleviate future morbidity from similar reactions with increased distribution of the vaccine.

19.
Arch Dermatol Res ; 313(6): 501-503, 2021 Aug.
Article in English | MEDLINE | ID: mdl-32388643

ABSTRACT

The COVID-19 pandemic has swept the globe with more than 2,000,000 confirmed cases of SARS-CoV-2 infection in 184 countries and territories. According to the Centers for Disease Control and Prevention (CDC), two crucial actions can reduce the risk of person-to-person viral transmission: frequent hand washing and surface decontamination with specific environmental protection agency (EPA)-registered disinfectants. As hygiene recommendations evolve during the COVID-19 pandemic and community members adopt changing practices, dermatologists are likely to see a rise in adverse cutaneous reactions from prolonged irritant exposures and widespread use of antimicrobials. The purposes of this report are to familiarize dermatologists with the hygiene practices recommended for COVID-19 prevention, to highlight adverse cutaneous reactions associated with repeated exposures to detergents and disinfectants, and to discuss strategies which patients can implement during the COVID-19 pandemic to minimize skin irritation white still performing hygiene practices effectively.


Subject(s)
COVID-19/prevention & control , Dermatitis, Contact/prevention & control , Dermatologists , Disinfectants/adverse effects , Hand Dermatoses/prevention & control , Hand Disinfection , Hygiene , SARS-CoV-2 , Humans
20.
Int J Dermatol ; 60(1): 25-32, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32516510

ABSTRACT

Erosive pustular dermatosis of the scalp is a rare condition which primarily affects older women after local trauma and has historically been treated with topical steroids. As it is a rare entity and resembles other dermatologic conditions, it may easily be misdiagnosed. Identifying the causes and evaluating the efficacy of treatments of erosive pustular dermatosis of the scalp (EPDS) is of great importance to both avoid misdiagnosis and ensure optimal treatment of this rare condition. There are numerous causes. In addition to surgeries and physical injuries, topical and procedural treatments for actinic keratoses and androgenetic alopecia can trigger the development of lesions. There are also documented associations with several autoimmune and systemic conditions. Besides corticosteroids, topical tacrolimus and photodynamic therapy were the most commonly used treatments for EPDS. They were effective with few recurrences and adverse effects. Other successful treatment options were topical dapsone, silicone gels, calcipotriol, acitretin, and isotretinoin. Oral dapsone can be used in cases of disseminated disease. Zinc sulfate should be considered with low-serum zinc levels. While cyclosporine was effective, there were adverse effects that may limit its use. It is important for dermatologists to be aware of the wide array of potential causes of erosive pustular dermatosis and include it on their differential. Additionally, although high-potency topical steroids have been historically used as the first-line treatment, there are many other effective treatments that may avoid recurrence and skin atrophy, particularly in the elderly population.


Subject(s)
Dermatologic Agents/therapeutic use , Scalp Dermatoses/drug therapy , Scalp Dermatoses/etiology , Acitretin/therapeutic use , Adrenal Cortex Hormones/therapeutic use , Aminolevulinic Acid/therapeutic use , Anti-Infective Agents/therapeutic use , Calcitriol/analogs & derivatives , Calcitriol/therapeutic use , Dapsone/therapeutic use , Humans , Immunosuppressive Agents/therapeutic use , Isotretinoin/therapeutic use , Keratolytic Agents/therapeutic use , Photochemotherapy , Tacrolimus/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL